Compare NBTX & BORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTX | BORR |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | France | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2018 | 2017 |
| Metric | NBTX | BORR |
|---|---|---|
| Price | $38.05 | $4.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $36.00 | $6.25 |
| AVG Volume (30 Days) | 119.2K | ★ 4.8M |
| Earning Date | 03-31-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $58.17 | $5.80 |
| Revenue Next Year | N/A | $21.67 |
| P/E Ratio | ★ N/A | $20.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.03 | $2.28 |
| 52 Week High | $57.14 | $6.66 |
| Indicator | NBTX | BORR |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 55.88 |
| Support Level | $34.83 | $4.10 |
| Resistance Level | $41.99 | $4.51 |
| Average True Range (ATR) | 1.99 | 0.22 |
| MACD | -0.09 | 0.06 |
| Stochastic Oscillator | 51.22 | 89.93 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.